AAAAAA
Results: 1-25/31
Authors:
Pujol, JL
Daures, JP
Riviere, A
Quoix, E
Westeel, V
Quantin, X
Breton, JL
Lemarie, E
Poudenx, M
Milleron, B
Moro, D
Debieuvre, D
Le Chevalier, T
Citation: Jl. Pujol et al., Etoposide plus cisplatin with or without the combination of 4 '-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: A French federation of cancer institutes multicenter phase III randomizedstudy, J NAT CANC, 93(4), 2001, pp. 300-308
Authors:
Le Chevalier, T
Citation: T. Le Chevalier, GEMZAR and new therapeutic approaches: chemotherapy in the new millennium for the treatment of thoracic cancer - Proceedings of a Satellite Symposiumto the 11th International Congress on Anti-Cancer Treatment held in Paris,7 February 2001, ANTI-CANC D, 12, 2001, pp. S1-S1
Authors:
Le Chevalier, T
Citation: T. Le Chevalier, Multi-targeted antifolate therapy for non-small cell lung cancer and mesothelioma, ANTI-CANC D, 12, 2001, pp. S21-S25
Authors:
Saghatchian, M
Fizazi, K
Borel, C
Ducreux, M
Ruffie, P
Le Chevalier, T
Theodore, C
Citation: M. Saghatchian et al., Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation - results of a prospective study, ANN ONCOL, 12(4), 2001, pp. 535-540
Authors:
Andre, F
Le Chevalier, T
Grunenwald, D
Citation: F. Andre et al., Subclassification of N2 non-small-cell lung cancer - In reply, J CL ONCOL, 19(4), 2001, pp. 1228-1228
Authors:
Novello, S
Le Chevalier, T
Citation: S. Novello et T. Le Chevalier, European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancer, SEMIN ONCOL, 28(4), 2001, pp. 3-9
Authors:
Arriagada, R
Pignon, J
Le Chevalier, T
Citation: R. Arriagada et al., Initial chemotherapeutic doses and long-term survival in limited small-cell lung cancer., N ENG J MED, 345(17), 2001, pp. 1281-1282
Authors:
Grunenwald, DH
Andre, F
Le Pechoux, C
Girard, P
Lamer, C
Laplanche, A
Tarayre, M
Arriagada, R
Le Chevalier, T
Citation: Dh. Grunenwald et al., Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer, J THOR SURG, 122(4), 2001, pp. 796-802
Authors:
Andre, F
Grunewald, D
Le Chevalier, T
Citation: F. Andre et al., Persistence of viable tumor cells after radiation and chemotherapy for stage IIIB non-small cell lung cancer: An early marker of treatment failure, J THOR SURG, 121(2), 2001, pp. 403-403
Authors:
Andre, F
Grunenwald, D
Pujol, JL
Girard, P
Dujon, A
Brouchet, L
Brichon, PY
Westeel, V
Le Chevalier, T
Citation: F. Andre et al., Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy Should prophylactic cranial irradiation be reconsidered?, CANCER, 91(12), 2001, pp. 2394-2400
Authors:
Bardet, E
Moro-Sibilot, D
Le Chevalier, T
Massard, G
Douillard, JY
Theobald, S
Astoul, P
Baldeyrou, P
Bazelly, B
Brechot, J
Breton, JL
Grivaux, M
Jacoulet, P
Khalil, A
Lemarie, E
Martinet, Y
Milleron, B
Paesmans, M
Pujol, JL
Quoix, AE
Ranfaing, E
Riviere, A
Sancho-Garnier, H
Souquet, PJ
Spaeth, D
Stoebner-Delbarre, A
Thiberville, L
Touboul, E
Vaylet, F
Vergnon, JM
Westeel, V
Depierre, A
Lagrange, JL
Citation: E. Bardet et al., Standards, Options and Recommendations for the management of locally advanced non small cell lung carcinoma, B CANCER, 88(4), 2001, pp. 369-387
Authors:
Jacot, W
Quantin, X
Boher, JM
Andre, F
Moreau, L
Gainet, M
Depierre, A
Quoix, E
Le Chevalier, T
Pujol, JL
Citation: W. Jacot et al., Brain metastases at the time of presentation of nonsmall cell lung cancer:a multi-centric AERIO analysis of prognostic factors, BR J CANC, 84(7), 2001, pp. 903-909
Authors:
Fizazi, K
Caliandro, R
Soulie, P
Fandi, A
Daniel, C
Bedin, A
Doubre, H
Viala, J
Rodier, JM
Trandafir, L
Le Chevalier, T
Cvitkovic, E
Armand, JP
Ruffie, P
Citation: K. Fizazi et al., Combination raltitrexed (Tomudex (R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma, EUR J CANC, 36(12), 2000, pp. 1514-1521
Authors:
Monnerat, C
Le Chevalier, T
Citation: C. Monnerat et T. Le Chevalier, Chemotherapy for non-small-cell lung carcinoma, a look at the past decade, ANN ONCOL, 11(7), 2000, pp. 773-776
Authors:
Delord, JP
Raymond, E
Chaouche, M
Ruffie, P
Ducreux, M
Faivre, S
Boige, V
Le Chevalier, T
Rixe, O
Baudin, E
Pautier, P
Rodier, JM
Chouaki, N
Escudier, B
Kayitalire, L
Armand, JP
Citation: Jp. Delord et al., A dose-finding study of gemcitabine and vinorelbine in advanced previouslytreated malignancies, ANN ONCOL, 11(1), 2000, pp. 73-79
Authors:
Escudier, B
Andre, F
Baldeyrou, P
Le Cesne, A
Le Chevalier, T
Tursz, T
Citation: B. Escudier et al., Gene therapy and lung cancer: today and tomorrow., REV MAL RES, 17(1), 2000, pp. 363-370
Authors:
Andre, F
Raymond, E
Doubre, H
Le Chevalier, T
Armand, JP
Citation: F. Andre et al., Cell targets of new drugs and results of new chemotherapy schemes in non-small-cell lung cancer., REV MAL RES, 17(1), 2000, pp. 417-424
Authors:
Andre, F
Grunenwald, D
Pignon, JP
Dujon, A
Pujol, JL
Brichon, PY
Brouchet, L
Quoix, E
Westeel, V
Le Chevalier, T
Citation: F. Andre et al., Survival of patients with resected N2 non-small-cell lung cancer: Evidencefor a subclassification and implications, J CL ONCOL, 18(16), 2000, pp. 2981-2989
Authors:
Marsiglia, H
Baldeyrou, P
Lartigau, E
Briot, E
Haie-Meder, C
Le Chevalier, T
Sasso, G
Gerbaulet, A
Citation: H. Marsiglia et al., High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma, INT J RAD O, 47(3), 2000, pp. 665-672
Authors:
Mattson, K
Bosquee, L
Dabouis, G
Le Groumellec, A
Pujol, JL
Marien, S
Stupp, R
Douillard, JY
Bragas, B
Berille, J
Olivares, R
Le Chevalier, T
Citation: K. Mattson et al., Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice, LUNG CANC, 29(3), 2000, pp. 205-216
Authors:
Meric, JB
Faivre, S
Monnerat, C
Vago, NA
Le Chevalier, T
Armand, JP
Raymond, E
Citation: Jb. Meric et al., ZD 1839 "Iressa", B CANCER, 87(12), 2000, pp. 873-876
Authors:
Le Cesne, A
Vassal, G
Farace, F
Spielmann, M
Le Chevalier, T
Angevin, E
Valteau-Couanet, D
Fizazi, K
Cojean, I
Llombard, A
Tursz, T
Escudier, B
Citation: A. Le Cesne et al., Combination interleukin-2 and doxorubicin in advanced adult solid tumors: Circumvention of doxorubicin resistance in soft-tissue sarcoma?, J IMMUNOTH, 22(3), 1999, pp. 268-277
Authors:
Merimsky, O
Le Chevalier, T
Missenard, G
Lepechoux, C
Cojean-Zelek, I
Mesurolle, B
Le Cesne, A
Citation: O. Merimsky et al., Management of cancer in pregnancy: A case of Ewing's sarcoma of the pelvisin the third trimester, ANN ONCOL, 10(3), 1999, pp. 345-350
Authors:
Le Chevalier, T
Citation: T. Le Chevalier, Non-platinum-based paclitaxel combinations in advanced non-small-cell lungcancer, ONCOLOGY-NY, 13(9), 1999, pp. 48-50
Authors:
Merimsky, O
Terrier, P
Stanca, A
Le Chevalier, T
Spielmann, M
Tursz, T
Le Cesne, A
Citation: O. Merimsky et al., Liver metastases from extremity soft tissue sarcoma, AM J CL ONC, 22(1), 1999, pp. 70-72